Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

被引:1
|
作者
Ammann, Markus [1 ,2 ]
Santol, Jonas [3 ]
Pereyra, David [2 ]
Kalchbrenner, Tamara [4 ]
Wuerger, Tanja [4 ]
Laengle, Johannes [2 ]
Smoot, Rory L. [5 ]
Hulla, Wolfgang [4 ]
Laengle, Friedrich [1 ]
Starlinger, Patrick [2 ,5 ]
机构
[1] State Hosp Wiener Neustadt, Dept Surg, Wiener Neustadt, Austria
[2] Med Univ Vienna, Div Visceral Surg, Dept Gen Surg, Vienna, Austria
[3] Clin Favoriten & Sigmund Freud Private Univ, Dept Surg, HPB Ctr, Viennese Hlth Network, Vienna, Austria
[4] State Hosp Wiener Neustadt, Dept Pathol, Wiener Neustadt, Austria
[5] Mayo Clin, Div Hepatobiliary & Pancreas Surg, Dept Surg, 200 First St SW, Rochester, MN 55905 USA
关键词
L CELLS; SECRETION; RECEPTOR; PROPOSAL; INSULIN; GLP-2; CHYLOMICRONS; INFLAMMATION; LIRAGLUTIDE; LPS;
D O I
10.1038/s41598-023-43283-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process. As such, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) critically affect hepatic regeneration in rodent models. The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF). GLP-1, GLP-2, Interleukin-6 (IL-6) and parameters of lipid metabolism were determined perioperatively in fasting plasma of 46 patients, who underwent liver resection. GLP-1 and GLP-2 demonstrated a rapid and consistently inverse time course during hepatic regeneration with a significant decrease of GLP-1 and increase of GLP-2 on POD1. Importantly, these postoperative dynamics were significantly more pronounced when PHLF occurred. Of note, the extent of resection or development of complications were not associated with these alterations. IL-6 mirrored the time course of GLP-2. Assessing the main degradation protein dipeptidyl peptidase 4 (DPP4) no significant association with either GLP-1 or -2 could be found. Additionally, in PHLF distinct postoperative declines in plasma lipid parameters were present and correlated with GLP-2 dynamics. Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses. Their close association with circulating markers of lipid metabolism and insufficient hepatic regeneration after liver surgery suggest a critical involvement during these processes in humans.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Markus Ammann
    Jonas Santol
    David Pereyra
    Tamara Kalchbrenner
    Tanja Wuerger
    Johannes Laengle
    Rory L. Smoot
    Wolfgang Hulla
    Friedrich Laengle
    Patrick Starlinger
    [J]. Scientific Reports, 13
  • [2] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [3] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [4] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    [J]. MICROCIRCULATION, 2019, 26 (03)
  • [5] Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1
    Nagell, CF
    Wettergren, A
    Pedersen, JF
    Mortensen, D
    Holst, JJ
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 353 - 358
  • [6] Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
    Brubaker, PL
    Anini, Y
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (11) : 1005 - 1012
  • [7] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [8] Glucagon-like peptide-2
    Estall, Jennifer L.
    Drucker, Daniel J.
    [J]. ANNUAL REVIEW OF NUTRITION, 2006, 26 : 391 - 411
  • [9] A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
    Lambeir, AM
    Proost, P
    Scharpé, S
    De Meester, I
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1753 - 1756
  • [10] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    [J]. RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399